1. Srinakharinwirot University Institutional Repository
  2. Articles from Academic Databases : SCOPUS
  3. Scopus 1983-2021
Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/17224
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPalawisuth S.
dc.contributor.authorNg J.N.C.
dc.contributor.authorPattanaprichakul P.
dc.contributor.authorNanchaipruek Y.
dc.contributor.authorJantanapornchai N.
dc.contributor.authorWanitphakdeedecha R.
dc.contributor.authorEimpunth S.
dc.date.accessioned2022-03-10T13:16:38Z-
dc.date.available2022-03-10T13:16:38Z-
dc.date.issued2021
dc.identifier.issn23525126
dc.identifier.other2-s2.0-85111097806
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/17224-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85111097806&doi=10.1016%2fj.jdcr.2021.06.001&partnerID=40&md5=1bf694c385e21a9aec8a2ff1d2b34511
dc.description.abstract[No abstract available]
dc.languageen
dc.subjectisotretinoin
dc.subjectledipasvir plus sofosbuvir
dc.subjectloratadine
dc.subjectprednisolone
dc.subjectribavirin
dc.subjectaged
dc.subjectArticle
dc.subjectcase report
dc.subjectcheek
dc.subjectclinical article
dc.subjectdrug dose reduction
dc.subjectechography
dc.subjectfemale
dc.subjectfollow up
dc.subjectforeign body granuloma
dc.subjecthistopathology
dc.subjecthuman
dc.subjecthuman tissue
dc.subjectincisional biopsy
dc.subjectlow drug dose
dc.subjectmedical history
dc.subjectmedical photography
dc.subjectphysical examination
dc.subjectsilicone granuloma
dc.titleSiliconoma successfully controlled with low-dose oral isotretinoin: A case report with histopathologic and ultrasonographic findings
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJAAD Case Reports. Vol 14, No. (2021), p.24-26
dc.identifier.doi10.1016/j.jdcr.2021.06.001
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.